Get the app
US › Healthcare

ABVC Biopharma Inc (ABVC)

US · Healthcare · Biotechnology

$1.15+6.48%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-736,934
EPS
$-0.03

Key statistics

Market cap
$26.1M
Forward P/E
0.0
P/B
2.55
Book value
$0.40
EPS (TTM)
$-0.29
52-week high
$3.40
52-week low
$0.71
50-day MA
$1.10
200-day MA
$1.48
Beta
0.61

Analyst view

Analysts rate ABVC Biopharma Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $2.02.

Shareholding

Insiders
18.11%
Institutions
4.09%

Largest institutional holders

FundStake
Geode Capital Management, LLC0.83%
Vanguard Capital Management, LLC0.71%
Vanguard Fiduciary Trust Co0.37%
Renaissance Technologies Corp0.36%
State Street Corp0.27%
BlackRock Inc0.21%
Panagora Asset Management Inc0.14%
Northern Trust Corp0.12%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for ABVC Biopharma Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.